PM Ridker, N Rifai, L Rose, JE Buring, NR … - New England Journal of Medicine, 2002 - content.nejm.org N Engl J Med, Vol. 347, No. 20 · November 14, 2002 · www.nejm.org · 1557 ...
C-REACTIVE PROTEIN AND LDL CHOLESTEROL FOR PREDICTING CARDIOVASCULAR EVENTS ...
COMPARISON OF C-REACTIVE PROTEIN AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL ... Cited by 2263 - Related articles - BL Direct - All 25 versions
PM Ridker - Circulation, 2003 - Am Heart Assoc In an attempt to improve global cardiovascular risk prediction, considerable
interest has focused on C-reactive protein (CRP), a marker of inflammation that
has been shown in multiple prospective epidemiological studies to predict ... Cited by 1118 - Related articles - BL Direct - All 11 versions
TP Erlinger, EA Platz, N Rifai, KJ Helzlsouer - Jama, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 186 - Related articles - BL Direct - All 5 versions
SS Bassuk, N Rifai, PM Ridker - Current Problems in Cardiology, 2004 - Elsevier High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation that
predicts incident myocardial infarction, stroke, peripheral arterial disease,
and sudden cardiac death among healthy individuals with no history of ... Cited by 171 - Related articles - All 10 versions
- ►endojournals.org S Davison, SR Davis - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc The role of estrogen in altering cardiovascular disease risk in women is
contentious. Menopause is associated with increased risk for ischemic heart
disease and cerebrovascular disease, which collectively are the main causes ... Cited by 99 - Related articles - BL Direct - All 4 versions
- ►endojournals.org V Fonseca, C Desouza, S Asnani, I Jialal - Endocrine reviews, 2004 - Endocrine Soc People with type 2 diabetes are disproportionately affected by cardiovascular
disease (CVD), compared with those without diabetes. Traditional risk factors do
not fully explain this excess risk, and other "nontraditional" risk factors ... Cited by 84 - Related articles - BL Direct - All 6 versions
NK Wenger - Progress in Cardiovascular Diseases, 2003 - Elsevier During the past decade, an overall theme has emerged, validating the exploration
of gender-based differences in coronary heart disease (CHD) as a basis for
clinical strategies to improve outcomes for women. Underrepresentation of ... Cited by 82 - Related articles - BL Direct - All 11 versions
- ►emcreg.org [PDF] JA Tice, W Browner, RP Tracy, SR Cummings - The American journal of medicine, 2001 - Elsevier We conducted a case-cohort study within the Study of Osteoporotic Fractures, a
population-based study involving 9704 women aged ≥65 years from four US
centers. We randomly selected 400 women from the entire cohort plus an ... Cited by 70 - Related articles - All 11 versions
- ►ahajournals.org KK Koh, MS Shin, I Sakuma, JY Ahn, DK Jin, … - Arteriosclerosis, thrombosis, and vascular biology, 2004 - Am Heart Assoc Methods and Results— This randomized, double-blind, crossover study included
57 women who received micronized progesterone 100 mg with either conjugated
equine estrogen 0.625 mg (C-HRT) or 0.3 mg (L-HRT) daily for 2 months. ... Cited by 60 - Related articles - BL Direct - All 10 versions
PM Ridker, SS Bassuk, PP Toth - Current Atherosclerosis Reports, 2003 - Springer Pathophysiology Early atheromatous lesion development consists of mono- cyte
adherence to, and transmigration through, the vascu- lar endothelium. Recent
laboratory data suggest that CRP potentiates these processes by ... Cited by 44 - Related articles - BL Direct - All 2 versions
